Global Parasomnia Treatment Market Growth (Status and Outlook) 2026-2032
The global Parasomnia Treatment market size is predicted to grow from US$ 378 million in 2025 to US$ 553 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.
Parasomnia Treatment refers to a comprehensive medical intervention system targeting abnormal sleep behaviors such as sleepwalking, night terrors, REM sleep behavior disorder, sleep paralysis, and related parasomnias. It includes pharmacological therapy, behavioral interventions, cognitive behavioral therapy (CBT), sleep hygiene management, and neurological modulation. The core objective is to regulate abnormal neurophysiological activities during sleep cycles, reduce risks associated with sleep?wake dissociation behaviors, and improve overall sleep quality and patient well-being. Built on the integration of sleep medicine, neuroscience, and psychiatry, it is widely applied in sleep centers, neurology, and psychiatric clinical pathways, representing a key component of modern sleep health management and neurobehavioral disorder treatment systems.The average gross profit margin of this product is 40%.
Against the backdrop of rising global sleep health burden, the parasomnia treatment market is entering a structural expansion phase. Industry reports and clinical data indicate that increasing stress levels, irregular lifestyles, and higher prevalence of psychiatric comorbidities are driving greater recognition of parasomnia disorders. Advances in sleep monitoring technologies such as polysomnography (PSG), wearable devices, and AI-based sleep analytics are improving diagnostic accessibility and expanding clinical detection rates. Meanwhile, pharmaceutical innovations in benzodiazepines, anticonvulsants, and antidepressants are providing diversified therapeutic pathways. Government initiatives integrating sleep health into public healthcare systems are further accelerating the expansion of specialized sleep centers, transforming the market from isolated drug-based therapy into an integrated ?diagnosis?intervention?long-term management? ecosystemThe industry continues to face multiple constraints. First, the heterogeneity and episodic nature of parasomnias make diagnosis highly dependent on specialized sleep studies and expert interpretation, increasing the risk of misdiagnosis or underdiagnosis. Second, treatment often involves psychotropic or sedative medications, which may lead to side effects and dependency concerns, limiting widespread clinical adoption. Third, sleep medicine resources remain concentrated in large hospitals, resulting in uneven regional accessibility. In addition, low patient awareness and limited proactive consultation behavior indicate that the market is still in an early education and awareness-building stage.Downstream demand is shifting from episodic treatment toward long-term sleep health management. Hospital demand is concentrated in neurology and sleep centers managing high-risk cases such as sleepwalking, night terrors, and REM sleep behavior disorder, while out-of-hospital demand is rapidly expanding among stressed populations, adolescents, and the elderly. The integration of digital sleep monitoring devices and telemedicine platforms enables continuous tracking and behavioral intervention, shifting treatment from reactive response to proactive management. Moreover, the strong comorbidity between psychiatric disorders and sleep disturbances is driving increased interdisciplinary demand across neurology and psychiatry, creating a converging growth pathway.The upstream ecosystem consists of pharmaceutical active ingredients, neuroregulatory compounds, medical devices, and digital sleep monitoring technologies. Pharmaceutical inputs include sedative-hypnotics, anticonvulsants, and antidepressant compounds that directly influence neurotransmitter regulation. Device infrastructure includes polysomnography systems, EEG devices, and wearable sensors, relying on advanced biomedical signal processing and electronic engineering. On the digital side, AI algorithms and sleep analytics platforms are emerging as critical infrastructure for abnormal sleep pattern detection. With the advancement of precision medicine, upstream players are evolving from standalone drug or device suppliers into integrated ?data?device?therapy? solution providers, driving deeper industry convergence and ecosystem integration.
LPI (LP Information)' newest research report, the ?Parasomnia Treatment Industry Forecast? looks at past sales and reviews total world Parasomnia Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Parasomnia Treatment sales for 2026 through 2032. With Parasomnia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parasomnia Treatment industry.
This Insight Report provides a comprehensive analysis of the global Parasomnia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Parasomnia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Parasomnia Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parasomnia Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parasomnia Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Parasomnia Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Parasomnia Treatment refers to a comprehensive medical intervention system targeting abnormal sleep behaviors such as sleepwalking, night terrors, REM sleep behavior disorder, sleep paralysis, and related parasomnias. It includes pharmacological therapy, behavioral interventions, cognitive behavioral therapy (CBT), sleep hygiene management, and neurological modulation. The core objective is to regulate abnormal neurophysiological activities during sleep cycles, reduce risks associated with sleep?wake dissociation behaviors, and improve overall sleep quality and patient well-being. Built on the integration of sleep medicine, neuroscience, and psychiatry, it is widely applied in sleep centers, neurology, and psychiatric clinical pathways, representing a key component of modern sleep health management and neurobehavioral disorder treatment systems.The average gross profit margin of this product is 40%.
Against the backdrop of rising global sleep health burden, the parasomnia treatment market is entering a structural expansion phase. Industry reports and clinical data indicate that increasing stress levels, irregular lifestyles, and higher prevalence of psychiatric comorbidities are driving greater recognition of parasomnia disorders. Advances in sleep monitoring technologies such as polysomnography (PSG), wearable devices, and AI-based sleep analytics are improving diagnostic accessibility and expanding clinical detection rates. Meanwhile, pharmaceutical innovations in benzodiazepines, anticonvulsants, and antidepressants are providing diversified therapeutic pathways. Government initiatives integrating sleep health into public healthcare systems are further accelerating the expansion of specialized sleep centers, transforming the market from isolated drug-based therapy into an integrated ?diagnosis?intervention?long-term management? ecosystemThe industry continues to face multiple constraints. First, the heterogeneity and episodic nature of parasomnias make diagnosis highly dependent on specialized sleep studies and expert interpretation, increasing the risk of misdiagnosis or underdiagnosis. Second, treatment often involves psychotropic or sedative medications, which may lead to side effects and dependency concerns, limiting widespread clinical adoption. Third, sleep medicine resources remain concentrated in large hospitals, resulting in uneven regional accessibility. In addition, low patient awareness and limited proactive consultation behavior indicate that the market is still in an early education and awareness-building stage.Downstream demand is shifting from episodic treatment toward long-term sleep health management. Hospital demand is concentrated in neurology and sleep centers managing high-risk cases such as sleepwalking, night terrors, and REM sleep behavior disorder, while out-of-hospital demand is rapidly expanding among stressed populations, adolescents, and the elderly. The integration of digital sleep monitoring devices and telemedicine platforms enables continuous tracking and behavioral intervention, shifting treatment from reactive response to proactive management. Moreover, the strong comorbidity between psychiatric disorders and sleep disturbances is driving increased interdisciplinary demand across neurology and psychiatry, creating a converging growth pathway.The upstream ecosystem consists of pharmaceutical active ingredients, neuroregulatory compounds, medical devices, and digital sleep monitoring technologies. Pharmaceutical inputs include sedative-hypnotics, anticonvulsants, and antidepressant compounds that directly influence neurotransmitter regulation. Device infrastructure includes polysomnography systems, EEG devices, and wearable sensors, relying on advanced biomedical signal processing and electronic engineering. On the digital side, AI algorithms and sleep analytics platforms are emerging as critical infrastructure for abnormal sleep pattern detection. With the advancement of precision medicine, upstream players are evolving from standalone drug or device suppliers into integrated ?data?device?therapy? solution providers, driving deeper industry convergence and ecosystem integration.
LPI (LP Information)' newest research report, the ?Parasomnia Treatment Industry Forecast? looks at past sales and reviews total world Parasomnia Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Parasomnia Treatment sales for 2026 through 2032. With Parasomnia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parasomnia Treatment industry.
This Insight Report provides a comprehensive analysis of the global Parasomnia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Parasomnia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Parasomnia Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parasomnia Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parasomnia Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Parasomnia Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Non-Rapid Eye Movement (NREM) Related Parasomnia
- Rapid Eye Movement (REM) Related Parasomnia
- Other Parasomnia
- Benzodiazepines
- Anticonvulsants
- Antidepressants
- Other
- Adult Patients
- Pediatric & Teens
- Elderly Patients
- Hospitals Pharmacies
- Retail Stores
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva Pharmaceutical
- Aurobindo Pharma
- Sun Pharmaceutical
- Takeda Pharmaceuticals
- Sanofi
- Intas Pharmaceuticals
- Sandoz International
- Merck
- Roche
- ResMed
- Philips Healthcare
- Fisher & Paykel Healthcare
- Natus Medical
- Compumedics
- Itamar Medical
- ProSomnus Sleep Technologies
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parasomnia Treatment Market Size (2021-2032)
2.1.2 Parasomnia Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Parasomnia Treatment by Country/Region (2021, 2025 & 2032)
2.2 Parasomnia Treatment Segment by Type
2.2.1 Non-Rapid Eye Movement (NREM) Related Parasomnia
2.2.2 Rapid Eye Movement (REM) Related Parasomnia
2.2.3 Other Parasomnia
2.2.4 Parasomnia Treatment Market Size by Type
2.2.4.1 Parasomnia Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Parasomnia Treatment Market Size Market Share by Type (2021-2026)
2.3 Parasomnia Treatment Segment by Treatment Type
2.3.1 Benzodiazepines
2.3.2 Anticonvulsants
2.3.3 Antidepressants
2.3.4 Other
2.3.5 Parasomnia Treatment Market Size by Treatment Type
2.3.5.1 Parasomnia Treatment Market Size CAGR by Treatment Type (2021 VS 2025 VS 2032)
2.3.5.2 Global Parasomnia Treatment Market Size Market Share by Treatment Type (2021-2026)
2.4 Parasomnia Treatment Segment by End Users
2.4.1 Adult Patients
2.4.2 Pediatric & Teens
2.4.3 Elderly Patients
2.4.4 Parasomnia Treatment Market Size by End Users
2.4.4.1 Parasomnia Treatment Market Size CAGR by End Users (2021 VS 2025 VS 2032)
2.4.4.2 Global Parasomnia Treatment Market Size Market Share by End Users (2021-2026)
2.5 Parasomnia Treatment Segment by Application
2.5.1 Hospitals Pharmacies
2.5.2 Retail Stores
2.5.3 Other
2.5.4 Parasomnia Treatment Market Size by Application
2.5.4.1 Parasomnia Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Parasomnia Treatment Market Size Market Share by Application (2021-2026)
3 PARASOMNIA TREATMENT MARKET SIZE BY PLAYER
3.1 Parasomnia Treatment Market Size Market Share by Player
3.1.1 Global Parasomnia Treatment Revenue by Player (2021-2026)
3.1.2 Global Parasomnia Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Parasomnia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARASOMNIA TREATMENT BY REGION
4.1 Parasomnia Treatment Market Size by Region (2021-2026)
4.2 Global Parasomnia Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Parasomnia Treatment Market Size Growth (2021-2026)
4.4 APAC Parasomnia Treatment Market Size Growth (2021-2026)
4.5 Europe Parasomnia Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Parasomnia Treatment Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Parasomnia Treatment Market Size by Country (2021-2026)
5.2 Americas Parasomnia Treatment Market Size by Type (2021-2026)
5.3 Americas Parasomnia Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parasomnia Treatment Market Size by Region (2021-2026)
6.2 APAC Parasomnia Treatment Market Size by Type (2021-2026)
6.3 APAC Parasomnia Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parasomnia Treatment Market Size by Country (2021-2026)
7.2 Europe Parasomnia Treatment Market Size by Type (2021-2026)
7.3 Europe Parasomnia Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parasomnia Treatment by Region (2021-2026)
8.2 Middle East & Africa Parasomnia Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Parasomnia Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARASOMNIA TREATMENT MARKET FORECAST
10.1 Global Parasomnia Treatment Forecast by Region (2027-2032)
10.1.1 Global Parasomnia Treatment Forecast by Region (2027-2032)
10.1.2 Americas Parasomnia Treatment Forecast
10.1.3 APAC Parasomnia Treatment Forecast
10.1.4 Europe Parasomnia Treatment Forecast
10.1.5 Middle East & Africa Parasomnia Treatment Forecast
10.2 Americas Parasomnia Treatment Forecast by Country (2027-2032)
10.2.1 United States Market Parasomnia Treatment Forecast
10.2.2 Canada Market Parasomnia Treatment Forecast
10.2.3 Mexico Market Parasomnia Treatment Forecast
10.2.4 Brazil Market Parasomnia Treatment Forecast
10.3 APAC Parasomnia Treatment Forecast by Region (2027-2032)
10.3.1 China Parasomnia Treatment Market Forecast
10.3.2 Japan Market Parasomnia Treatment Forecast
10.3.3 Korea Market Parasomnia Treatment Forecast
10.3.4 Southeast Asia Market Parasomnia Treatment Forecast
10.3.5 India Market Parasomnia Treatment Forecast
10.3.6 Australia Market Parasomnia Treatment Forecast
10.4 Europe Parasomnia Treatment Forecast by Country (2027-2032)
10.4.1 Germany Market Parasomnia Treatment Forecast
10.4.2 France Market Parasomnia Treatment Forecast
10.4.3 UK Market Parasomnia Treatment Forecast
10.4.4 Italy Market Parasomnia Treatment Forecast
10.4.5 Russia Market Parasomnia Treatment Forecast
10.5 Middle East & Africa Parasomnia Treatment Forecast by Region (2027-2032)
10.5.1 Egypt Market Parasomnia Treatment Forecast
10.5.2 South Africa Market Parasomnia Treatment Forecast
10.5.3 Israel Market Parasomnia Treatment Forecast
10.5.4 Turkey Market Parasomnia Treatment Forecast
10.6 Global Parasomnia Treatment Forecast by Type (2027-2032)
10.7 Global Parasomnia Treatment Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Parasomnia Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Parasomnia Treatment Product Offered
11.1.3 Pfizer Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Information
11.2.2 Teva Pharmaceutical Parasomnia Treatment Product Offered
11.2.3 Teva Pharmaceutical Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Teva Pharmaceutical Main Business Overview
11.2.5 Teva Pharmaceutical Latest Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Parasomnia Treatment Product Offered
11.3.3 Aurobindo Pharma Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Aurobindo Pharma Main Business Overview
11.3.5 Aurobindo Pharma Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Parasomnia Treatment Product Offered
11.4.3 Sun Pharmaceutical Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Takeda Pharmaceuticals
11.5.1 Takeda Pharmaceuticals Company Information
11.5.2 Takeda Pharmaceuticals Parasomnia Treatment Product Offered
11.5.3 Takeda Pharmaceuticals Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Takeda Pharmaceuticals Main Business Overview
11.5.5 Takeda Pharmaceuticals Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Parasomnia Treatment Product Offered
11.6.3 Sanofi Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Intas Pharmaceuticals
11.7.1 Intas Pharmaceuticals Company Information
11.7.2 Intas Pharmaceuticals Parasomnia Treatment Product Offered
11.7.3 Intas Pharmaceuticals Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Intas Pharmaceuticals Main Business Overview
11.7.5 Intas Pharmaceuticals Latest Developments
11.8 Sandoz International
11.8.1 Sandoz International Company Information
11.8.2 Sandoz International Parasomnia Treatment Product Offered
11.8.3 Sandoz International Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sandoz International Main Business Overview
11.8.5 Sandoz International Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Parasomnia Treatment Product Offered
11.9.3 Merck Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Parasomnia Treatment Product Offered
11.10.3 Roche Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 ResMed
11.11.1 ResMed Company Information
11.11.2 ResMed Parasomnia Treatment Product Offered
11.11.3 ResMed Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ResMed Main Business Overview
11.11.5 ResMed Latest Developments
11.12 Philips Healthcare
11.12.1 Philips Healthcare Company Information
11.12.2 Philips Healthcare Parasomnia Treatment Product Offered
11.12.3 Philips Healthcare Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Philips Healthcare Main Business Overview
11.12.5 Philips Healthcare Latest Developments
11.13 Fisher & Paykel Healthcare
11.13.1 Fisher & Paykel Healthcare Company Information
11.13.2 Fisher & Paykel Healthcare Parasomnia Treatment Product Offered
11.13.3 Fisher & Paykel Healthcare Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Fisher & Paykel Healthcare Main Business Overview
11.13.5 Fisher & Paykel Healthcare Latest Developments
11.14 Natus Medical
11.14.1 Natus Medical Company Information
11.14.2 Natus Medical Parasomnia Treatment Product Offered
11.14.3 Natus Medical Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Natus Medical Main Business Overview
11.14.5 Natus Medical Latest Developments
11.15 Compumedics
11.15.1 Compumedics Company Information
11.15.2 Compumedics Parasomnia Treatment Product Offered
11.15.3 Compumedics Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Compumedics Main Business Overview
11.15.5 Compumedics Latest Developments
11.16 Itamar Medical
11.16.1 Itamar Medical Company Information
11.16.2 Itamar Medical Parasomnia Treatment Product Offered
11.16.3 Itamar Medical Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Itamar Medical Main Business Overview
11.16.5 Itamar Medical Latest Developments
11.17 ProSomnus Sleep Technologies
11.17.1 ProSomnus Sleep Technologies Company Information
11.17.2 ProSomnus Sleep Technologies Parasomnia Treatment Product Offered
11.17.3 ProSomnus Sleep Technologies Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 ProSomnus Sleep Technologies Main Business Overview
11.17.5 ProSomnus Sleep Technologies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parasomnia Treatment Market Size (2021-2032)
2.1.2 Parasomnia Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Parasomnia Treatment by Country/Region (2021, 2025 & 2032)
2.2 Parasomnia Treatment Segment by Type
2.2.1 Non-Rapid Eye Movement (NREM) Related Parasomnia
2.2.2 Rapid Eye Movement (REM) Related Parasomnia
2.2.3 Other Parasomnia
2.2.4 Parasomnia Treatment Market Size by Type
2.2.4.1 Parasomnia Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Parasomnia Treatment Market Size Market Share by Type (2021-2026)
2.3 Parasomnia Treatment Segment by Treatment Type
2.3.1 Benzodiazepines
2.3.2 Anticonvulsants
2.3.3 Antidepressants
2.3.4 Other
2.3.5 Parasomnia Treatment Market Size by Treatment Type
2.3.5.1 Parasomnia Treatment Market Size CAGR by Treatment Type (2021 VS 2025 VS 2032)
2.3.5.2 Global Parasomnia Treatment Market Size Market Share by Treatment Type (2021-2026)
2.4 Parasomnia Treatment Segment by End Users
2.4.1 Adult Patients
2.4.2 Pediatric & Teens
2.4.3 Elderly Patients
2.4.4 Parasomnia Treatment Market Size by End Users
2.4.4.1 Parasomnia Treatment Market Size CAGR by End Users (2021 VS 2025 VS 2032)
2.4.4.2 Global Parasomnia Treatment Market Size Market Share by End Users (2021-2026)
2.5 Parasomnia Treatment Segment by Application
2.5.1 Hospitals Pharmacies
2.5.2 Retail Stores
2.5.3 Other
2.5.4 Parasomnia Treatment Market Size by Application
2.5.4.1 Parasomnia Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Parasomnia Treatment Market Size Market Share by Application (2021-2026)
3 PARASOMNIA TREATMENT MARKET SIZE BY PLAYER
3.1 Parasomnia Treatment Market Size Market Share by Player
3.1.1 Global Parasomnia Treatment Revenue by Player (2021-2026)
3.1.2 Global Parasomnia Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Parasomnia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARASOMNIA TREATMENT BY REGION
4.1 Parasomnia Treatment Market Size by Region (2021-2026)
4.2 Global Parasomnia Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Parasomnia Treatment Market Size Growth (2021-2026)
4.4 APAC Parasomnia Treatment Market Size Growth (2021-2026)
4.5 Europe Parasomnia Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Parasomnia Treatment Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Parasomnia Treatment Market Size by Country (2021-2026)
5.2 Americas Parasomnia Treatment Market Size by Type (2021-2026)
5.3 Americas Parasomnia Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parasomnia Treatment Market Size by Region (2021-2026)
6.2 APAC Parasomnia Treatment Market Size by Type (2021-2026)
6.3 APAC Parasomnia Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parasomnia Treatment Market Size by Country (2021-2026)
7.2 Europe Parasomnia Treatment Market Size by Type (2021-2026)
7.3 Europe Parasomnia Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parasomnia Treatment by Region (2021-2026)
8.2 Middle East & Africa Parasomnia Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Parasomnia Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARASOMNIA TREATMENT MARKET FORECAST
10.1 Global Parasomnia Treatment Forecast by Region (2027-2032)
10.1.1 Global Parasomnia Treatment Forecast by Region (2027-2032)
10.1.2 Americas Parasomnia Treatment Forecast
10.1.3 APAC Parasomnia Treatment Forecast
10.1.4 Europe Parasomnia Treatment Forecast
10.1.5 Middle East & Africa Parasomnia Treatment Forecast
10.2 Americas Parasomnia Treatment Forecast by Country (2027-2032)
10.2.1 United States Market Parasomnia Treatment Forecast
10.2.2 Canada Market Parasomnia Treatment Forecast
10.2.3 Mexico Market Parasomnia Treatment Forecast
10.2.4 Brazil Market Parasomnia Treatment Forecast
10.3 APAC Parasomnia Treatment Forecast by Region (2027-2032)
10.3.1 China Parasomnia Treatment Market Forecast
10.3.2 Japan Market Parasomnia Treatment Forecast
10.3.3 Korea Market Parasomnia Treatment Forecast
10.3.4 Southeast Asia Market Parasomnia Treatment Forecast
10.3.5 India Market Parasomnia Treatment Forecast
10.3.6 Australia Market Parasomnia Treatment Forecast
10.4 Europe Parasomnia Treatment Forecast by Country (2027-2032)
10.4.1 Germany Market Parasomnia Treatment Forecast
10.4.2 France Market Parasomnia Treatment Forecast
10.4.3 UK Market Parasomnia Treatment Forecast
10.4.4 Italy Market Parasomnia Treatment Forecast
10.4.5 Russia Market Parasomnia Treatment Forecast
10.5 Middle East & Africa Parasomnia Treatment Forecast by Region (2027-2032)
10.5.1 Egypt Market Parasomnia Treatment Forecast
10.5.2 South Africa Market Parasomnia Treatment Forecast
10.5.3 Israel Market Parasomnia Treatment Forecast
10.5.4 Turkey Market Parasomnia Treatment Forecast
10.6 Global Parasomnia Treatment Forecast by Type (2027-2032)
10.7 Global Parasomnia Treatment Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Parasomnia Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Parasomnia Treatment Product Offered
11.1.3 Pfizer Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Information
11.2.2 Teva Pharmaceutical Parasomnia Treatment Product Offered
11.2.3 Teva Pharmaceutical Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Teva Pharmaceutical Main Business Overview
11.2.5 Teva Pharmaceutical Latest Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Parasomnia Treatment Product Offered
11.3.3 Aurobindo Pharma Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Aurobindo Pharma Main Business Overview
11.3.5 Aurobindo Pharma Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Parasomnia Treatment Product Offered
11.4.3 Sun Pharmaceutical Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Takeda Pharmaceuticals
11.5.1 Takeda Pharmaceuticals Company Information
11.5.2 Takeda Pharmaceuticals Parasomnia Treatment Product Offered
11.5.3 Takeda Pharmaceuticals Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Takeda Pharmaceuticals Main Business Overview
11.5.5 Takeda Pharmaceuticals Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Parasomnia Treatment Product Offered
11.6.3 Sanofi Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Intas Pharmaceuticals
11.7.1 Intas Pharmaceuticals Company Information
11.7.2 Intas Pharmaceuticals Parasomnia Treatment Product Offered
11.7.3 Intas Pharmaceuticals Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Intas Pharmaceuticals Main Business Overview
11.7.5 Intas Pharmaceuticals Latest Developments
11.8 Sandoz International
11.8.1 Sandoz International Company Information
11.8.2 Sandoz International Parasomnia Treatment Product Offered
11.8.3 Sandoz International Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sandoz International Main Business Overview
11.8.5 Sandoz International Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Parasomnia Treatment Product Offered
11.9.3 Merck Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Parasomnia Treatment Product Offered
11.10.3 Roche Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 ResMed
11.11.1 ResMed Company Information
11.11.2 ResMed Parasomnia Treatment Product Offered
11.11.3 ResMed Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ResMed Main Business Overview
11.11.5 ResMed Latest Developments
11.12 Philips Healthcare
11.12.1 Philips Healthcare Company Information
11.12.2 Philips Healthcare Parasomnia Treatment Product Offered
11.12.3 Philips Healthcare Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Philips Healthcare Main Business Overview
11.12.5 Philips Healthcare Latest Developments
11.13 Fisher & Paykel Healthcare
11.13.1 Fisher & Paykel Healthcare Company Information
11.13.2 Fisher & Paykel Healthcare Parasomnia Treatment Product Offered
11.13.3 Fisher & Paykel Healthcare Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Fisher & Paykel Healthcare Main Business Overview
11.13.5 Fisher & Paykel Healthcare Latest Developments
11.14 Natus Medical
11.14.1 Natus Medical Company Information
11.14.2 Natus Medical Parasomnia Treatment Product Offered
11.14.3 Natus Medical Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Natus Medical Main Business Overview
11.14.5 Natus Medical Latest Developments
11.15 Compumedics
11.15.1 Compumedics Company Information
11.15.2 Compumedics Parasomnia Treatment Product Offered
11.15.3 Compumedics Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Compumedics Main Business Overview
11.15.5 Compumedics Latest Developments
11.16 Itamar Medical
11.16.1 Itamar Medical Company Information
11.16.2 Itamar Medical Parasomnia Treatment Product Offered
11.16.3 Itamar Medical Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Itamar Medical Main Business Overview
11.16.5 Itamar Medical Latest Developments
11.17 ProSomnus Sleep Technologies
11.17.1 ProSomnus Sleep Technologies Company Information
11.17.2 ProSomnus Sleep Technologies Parasomnia Treatment Product Offered
11.17.3 ProSomnus Sleep Technologies Parasomnia Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 ProSomnus Sleep Technologies Main Business Overview
11.17.5 ProSomnus Sleep Technologies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Parasomnia Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Parasomnia Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Rapid Eye Movement (NREM) Related Parasomnia
Table 4. Major Players of Rapid Eye Movement (REM) Related Parasomnia
Table 5. Major Players of Other Parasomnia
Table 6. Parasomnia Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Benzodiazepines
Table 10. Major Players of Anticonvulsants
Table 11. Major Players of Antidepressants
Table 12. Major Players of Other
Table 13. Parasomnia Treatment Market Size CAGR by Treatment Type (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Parasomnia Treatment Market Size by Treatment Type (2021-2026) & ($ millions)
Table 15. Global Parasomnia Treatment Market Size Market Share by Treatment Type (2021-2026)
Table 16. Major Players of Adult Patients
Table 17. Major Players of Pediatric & Teens
Table 18. Major Players of Elderly Patients
Table 19. Parasomnia Treatment Market Size CAGR by End Users (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Parasomnia Treatment Market Size by End Users (2021-2026) & ($ millions)
Table 21. Global Parasomnia Treatment Market Size Market Share by End Users (2021-2026)
Table 22. Parasomnia Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Table 25. Global Parasomnia Treatment Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Parasomnia Treatment Revenue Market Share by Player (2021-2026)
Table 27. Parasomnia Treatment Key Players Head office and Products Offered
Table 28. Parasomnia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Parasomnia Treatment Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Parasomnia Treatment Market Size Market Share by Region (2021-2026)
Table 33. Global Parasomnia Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Parasomnia Treatment Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Parasomnia Treatment Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Parasomnia Treatment Market Size Market Share by Country (2021-2026)
Table 37. Americas Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Table 39. Americas Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Table 41. APAC Parasomnia Treatment Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Parasomnia Treatment Market Size Market Share by Region (2021-2026)
Table 43. APAC Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Parasomnia Treatment Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Parasomnia Treatment Market Size Market Share by Country (2021-2026)
Table 47. Europe Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Parasomnia Treatment Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Parasomnia Treatment
Table 53. Key Market Challenges & Risks of Parasomnia Treatment
Table 54. Key Industry Trends of Parasomnia Treatment
Table 55. Global Parasomnia Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Parasomnia Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Parasomnia Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Parasomnia Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Pfizer Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 60. Pfizer Parasomnia Treatment Product Offered
Table 61. Pfizer Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Pfizer Main Business
Table 63. Pfizer Latest Developments
Table 64. Teva Pharmaceutical Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 65. Teva Pharmaceutical Parasomnia Treatment Product Offered
Table 66. Teva Pharmaceutical Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Teva Pharmaceutical Main Business
Table 68. Teva Pharmaceutical Latest Developments
Table 69. Aurobindo Pharma Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 70. Aurobindo Pharma Parasomnia Treatment Product Offered
Table 71. Aurobindo Pharma Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Aurobindo Pharma Main Business
Table 73. Aurobindo Pharma Latest Developments
Table 74. Sun Pharmaceutical Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 75. Sun Pharmaceutical Parasomnia Treatment Product Offered
Table 76. Sun Pharmaceutical Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Sun Pharmaceutical Main Business
Table 78. Sun Pharmaceutical Latest Developments
Table 79. Takeda Pharmaceuticals Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 80. Takeda Pharmaceuticals Parasomnia Treatment Product Offered
Table 81. Takeda Pharmaceuticals Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Takeda Pharmaceuticals Main Business
Table 83. Takeda Pharmaceuticals Latest Developments
Table 84. Sanofi Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 85. Sanofi Parasomnia Treatment Product Offered
Table 86. Sanofi Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Intas Pharmaceuticals Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 90. Intas Pharmaceuticals Parasomnia Treatment Product Offered
Table 91. Intas Pharmaceuticals Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Intas Pharmaceuticals Main Business
Table 93. Intas Pharmaceuticals Latest Developments
Table 94. Sandoz International Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 95. Sandoz International Parasomnia Treatment Product Offered
Table 96. Sandoz International Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Sandoz International Main Business
Table 98. Sandoz International Latest Developments
Table 99. Merck Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 100. Merck Parasomnia Treatment Product Offered
Table 101. Merck Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Roche Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 105. Roche Parasomnia Treatment Product Offered
Table 106. Roche Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Roche Main Business
Table 108. Roche Latest Developments
Table 109. ResMed Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 110. ResMed Parasomnia Treatment Product Offered
Table 111. ResMed Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. ResMed Main Business
Table 113. ResMed Latest Developments
Table 114. Philips Healthcare Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 115. Philips Healthcare Parasomnia Treatment Product Offered
Table 116. Philips Healthcare Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Philips Healthcare Main Business
Table 118. Philips Healthcare Latest Developments
Table 119. Fisher & Paykel Healthcare Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 120. Fisher & Paykel Healthcare Parasomnia Treatment Product Offered
Table 121. Fisher & Paykel Healthcare Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Fisher & Paykel Healthcare Main Business
Table 123. Fisher & Paykel Healthcare Latest Developments
Table 124. Natus Medical Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 125. Natus Medical Parasomnia Treatment Product Offered
Table 126. Natus Medical Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Natus Medical Main Business
Table 128. Natus Medical Latest Developments
Table 129. Compumedics Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 130. Compumedics Parasomnia Treatment Product Offered
Table 131. Compumedics Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Compumedics Main Business
Table 133. Compumedics Latest Developments
Table 134. Itamar Medical Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 135. Itamar Medical Parasomnia Treatment Product Offered
Table 136. Itamar Medical Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Itamar Medical Main Business
Table 138. Itamar Medical Latest Developments
Table 139. ProSomnus Sleep Technologies Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 140. ProSomnus Sleep Technologies Parasomnia Treatment Product Offered
Table 141. ProSomnus Sleep Technologies Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. ProSomnus Sleep Technologies Main Business
Table 143. ProSomnus Sleep Technologies Latest Developments
Table 1. Parasomnia Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Parasomnia Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Rapid Eye Movement (NREM) Related Parasomnia
Table 4. Major Players of Rapid Eye Movement (REM) Related Parasomnia
Table 5. Major Players of Other Parasomnia
Table 6. Parasomnia Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Benzodiazepines
Table 10. Major Players of Anticonvulsants
Table 11. Major Players of Antidepressants
Table 12. Major Players of Other
Table 13. Parasomnia Treatment Market Size CAGR by Treatment Type (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Parasomnia Treatment Market Size by Treatment Type (2021-2026) & ($ millions)
Table 15. Global Parasomnia Treatment Market Size Market Share by Treatment Type (2021-2026)
Table 16. Major Players of Adult Patients
Table 17. Major Players of Pediatric & Teens
Table 18. Major Players of Elderly Patients
Table 19. Parasomnia Treatment Market Size CAGR by End Users (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Parasomnia Treatment Market Size by End Users (2021-2026) & ($ millions)
Table 21. Global Parasomnia Treatment Market Size Market Share by End Users (2021-2026)
Table 22. Parasomnia Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Table 25. Global Parasomnia Treatment Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Parasomnia Treatment Revenue Market Share by Player (2021-2026)
Table 27. Parasomnia Treatment Key Players Head office and Products Offered
Table 28. Parasomnia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Parasomnia Treatment Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Parasomnia Treatment Market Size Market Share by Region (2021-2026)
Table 33. Global Parasomnia Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Parasomnia Treatment Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Parasomnia Treatment Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Parasomnia Treatment Market Size Market Share by Country (2021-2026)
Table 37. Americas Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Table 39. Americas Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Table 41. APAC Parasomnia Treatment Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Parasomnia Treatment Market Size Market Share by Region (2021-2026)
Table 43. APAC Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Parasomnia Treatment Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Parasomnia Treatment Market Size Market Share by Country (2021-2026)
Table 47. Europe Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Parasomnia Treatment Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Parasomnia Treatment Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Parasomnia Treatment Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Parasomnia Treatment
Table 53. Key Market Challenges & Risks of Parasomnia Treatment
Table 54. Key Industry Trends of Parasomnia Treatment
Table 55. Global Parasomnia Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Parasomnia Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Parasomnia Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Parasomnia Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Pfizer Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 60. Pfizer Parasomnia Treatment Product Offered
Table 61. Pfizer Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Pfizer Main Business
Table 63. Pfizer Latest Developments
Table 64. Teva Pharmaceutical Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 65. Teva Pharmaceutical Parasomnia Treatment Product Offered
Table 66. Teva Pharmaceutical Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Teva Pharmaceutical Main Business
Table 68. Teva Pharmaceutical Latest Developments
Table 69. Aurobindo Pharma Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 70. Aurobindo Pharma Parasomnia Treatment Product Offered
Table 71. Aurobindo Pharma Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Aurobindo Pharma Main Business
Table 73. Aurobindo Pharma Latest Developments
Table 74. Sun Pharmaceutical Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 75. Sun Pharmaceutical Parasomnia Treatment Product Offered
Table 76. Sun Pharmaceutical Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Sun Pharmaceutical Main Business
Table 78. Sun Pharmaceutical Latest Developments
Table 79. Takeda Pharmaceuticals Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 80. Takeda Pharmaceuticals Parasomnia Treatment Product Offered
Table 81. Takeda Pharmaceuticals Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Takeda Pharmaceuticals Main Business
Table 83. Takeda Pharmaceuticals Latest Developments
Table 84. Sanofi Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 85. Sanofi Parasomnia Treatment Product Offered
Table 86. Sanofi Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Intas Pharmaceuticals Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 90. Intas Pharmaceuticals Parasomnia Treatment Product Offered
Table 91. Intas Pharmaceuticals Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Intas Pharmaceuticals Main Business
Table 93. Intas Pharmaceuticals Latest Developments
Table 94. Sandoz International Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 95. Sandoz International Parasomnia Treatment Product Offered
Table 96. Sandoz International Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Sandoz International Main Business
Table 98. Sandoz International Latest Developments
Table 99. Merck Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 100. Merck Parasomnia Treatment Product Offered
Table 101. Merck Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Roche Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 105. Roche Parasomnia Treatment Product Offered
Table 106. Roche Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Roche Main Business
Table 108. Roche Latest Developments
Table 109. ResMed Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 110. ResMed Parasomnia Treatment Product Offered
Table 111. ResMed Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. ResMed Main Business
Table 113. ResMed Latest Developments
Table 114. Philips Healthcare Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 115. Philips Healthcare Parasomnia Treatment Product Offered
Table 116. Philips Healthcare Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Philips Healthcare Main Business
Table 118. Philips Healthcare Latest Developments
Table 119. Fisher & Paykel Healthcare Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 120. Fisher & Paykel Healthcare Parasomnia Treatment Product Offered
Table 121. Fisher & Paykel Healthcare Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Fisher & Paykel Healthcare Main Business
Table 123. Fisher & Paykel Healthcare Latest Developments
Table 124. Natus Medical Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 125. Natus Medical Parasomnia Treatment Product Offered
Table 126. Natus Medical Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Natus Medical Main Business
Table 128. Natus Medical Latest Developments
Table 129. Compumedics Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 130. Compumedics Parasomnia Treatment Product Offered
Table 131. Compumedics Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Compumedics Main Business
Table 133. Compumedics Latest Developments
Table 134. Itamar Medical Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 135. Itamar Medical Parasomnia Treatment Product Offered
Table 136. Itamar Medical Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Itamar Medical Main Business
Table 138. Itamar Medical Latest Developments
Table 139. ProSomnus Sleep Technologies Details, Company Type, Parasomnia Treatment Area Served and Its Competitors
Table 140. ProSomnus Sleep Technologies Parasomnia Treatment Product Offered
Table 141. ProSomnus Sleep Technologies Parasomnia Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. ProSomnus Sleep Technologies Main Business
Table 143. ProSomnus Sleep Technologies Latest Developments
LIST OF FIGURES
Figure 1. Parasomnia Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parasomnia Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Parasomnia Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Parasomnia Treatment Sales Market Share by Country/Region (2025)
Figure 8. Parasomnia Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Parasomnia Treatment Market Size Market Share by Type in 2025
Figure 10. Global Parasomnia Treatment Market Size Market Share by Treatment Type in 2025
Figure 11. Global Parasomnia Treatment Market Size Market Share by End Users in 2025
Figure 12. Parasomnia Treatment in Hospitals Pharmacies
Figure 13. Global Parasomnia Treatment Market: Hospitals Pharmacies (2021-2026) & ($ millions)
Figure 14. Parasomnia Treatment in Retail Stores
Figure 15. Global Parasomnia Treatment Market: Retail Stores (2021-2026) & ($ millions)
Figure 16. Parasomnia Treatment in Other
Figure 17. Global Parasomnia Treatment Market: Other (2021-2026) & ($ millions)
Figure 18. Global Parasomnia Treatment Market Size Market Share by Application in 2025
Figure 19. Global Parasomnia Treatment Revenue Market Share by Player in 2025
Figure 20. Global Parasomnia Treatment Market Size Market Share by Region (2021-2026)
Figure 21. Americas Parasomnia Treatment Market Size 2021-2026 ($ millions)
Figure 22. APAC Parasomnia Treatment Market Size 2021-2026 ($ millions)
Figure 23. Europe Parasomnia Treatment Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Parasomnia Treatment Market Size 2021-2026 ($ millions)
Figure 25. Americas Parasomnia Treatment Value Market Share by Country in 2025
Figure 26. United States Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Parasomnia Treatment Market Size Market Share by Region in 2025
Figure 31. APAC Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Figure 32. APAC Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Figure 33. China Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. India Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Parasomnia Treatment Market Size Market Share by Country in 2025
Figure 40. Europe Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Figure 41. Europe Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Figure 42. Germany Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. France Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Parasomnia Treatment Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 56. APAC Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 57. Europe Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 59. United States Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 60. Canada Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 61. Mexico Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 62. Brazil Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 63. China Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 64. Japan Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 65. Korea Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 67. India Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 68. Australia Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 69. Germany Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 70. France Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 71. UK Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 72. Italy Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 73. Russia Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 74. Egypt Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 75. South Africa Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 76. Israel Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 77. Turkey Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 78. Global Parasomnia Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Parasomnia Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 1. Parasomnia Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parasomnia Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Parasomnia Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Parasomnia Treatment Sales Market Share by Country/Region (2025)
Figure 8. Parasomnia Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Parasomnia Treatment Market Size Market Share by Type in 2025
Figure 10. Global Parasomnia Treatment Market Size Market Share by Treatment Type in 2025
Figure 11. Global Parasomnia Treatment Market Size Market Share by End Users in 2025
Figure 12. Parasomnia Treatment in Hospitals Pharmacies
Figure 13. Global Parasomnia Treatment Market: Hospitals Pharmacies (2021-2026) & ($ millions)
Figure 14. Parasomnia Treatment in Retail Stores
Figure 15. Global Parasomnia Treatment Market: Retail Stores (2021-2026) & ($ millions)
Figure 16. Parasomnia Treatment in Other
Figure 17. Global Parasomnia Treatment Market: Other (2021-2026) & ($ millions)
Figure 18. Global Parasomnia Treatment Market Size Market Share by Application in 2025
Figure 19. Global Parasomnia Treatment Revenue Market Share by Player in 2025
Figure 20. Global Parasomnia Treatment Market Size Market Share by Region (2021-2026)
Figure 21. Americas Parasomnia Treatment Market Size 2021-2026 ($ millions)
Figure 22. APAC Parasomnia Treatment Market Size 2021-2026 ($ millions)
Figure 23. Europe Parasomnia Treatment Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Parasomnia Treatment Market Size 2021-2026 ($ millions)
Figure 25. Americas Parasomnia Treatment Value Market Share by Country in 2025
Figure 26. United States Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Parasomnia Treatment Market Size Market Share by Region in 2025
Figure 31. APAC Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Figure 32. APAC Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Figure 33. China Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. India Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Parasomnia Treatment Market Size Market Share by Country in 2025
Figure 40. Europe Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Figure 41. Europe Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Figure 42. Germany Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. France Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Parasomnia Treatment Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Parasomnia Treatment Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Parasomnia Treatment Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Parasomnia Treatment Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 56. APAC Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 57. Europe Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 59. United States Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 60. Canada Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 61. Mexico Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 62. Brazil Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 63. China Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 64. Japan Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 65. Korea Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 67. India Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 68. Australia Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 69. Germany Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 70. France Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 71. UK Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 72. Italy Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 73. Russia Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 74. Egypt Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 75. South Africa Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 76. Israel Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 77. Turkey Parasomnia Treatment Market Size 2027-2032 ($ millions)
Figure 78. Global Parasomnia Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Parasomnia Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Parasomnia Treatment Market Size 2027-2032 ($ millions)
